Influence of germline variations in drug transporters ABCB1 and ABCG2 on intracerebral osimertinib efficacy in patients with non-small cell lung cancer

G. D. Marijn Veerman*, Rene J. Boosman, Esther Oomen-de Hoop, Anthonie J. van der Wekken, Idris Bahce, Lizza E. L. Hendriks, Sander Croes, Christi M. J. Steendam, Evert de Jonge, Stijn L. W. Koolen, Neeltje Steeghs, Ron H. N. van Schaik, Egbert F. Smit, Anne-Marie C. Dingemans, Alwin D. R. Huitema, Ron H. J. Mathijssen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Influence of germline variations in drug transporters ABCB1 and ABCG2 on intracerebral osimertinib efficacy in patients with non-small cell lung cancer'. Together they form a unique fingerprint.

Keyphrases

INIS

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology